This project team will create a paper with recommendations for listings to include in Clinical Study Reports based on shared learning from cross-industry participants, to address changes in data availability over time.
White Paper providing recommendations for listings to include CSRs and submissions (if any), with a summary of example alternatives to static listings.
Public review - Q12021
Final paper - Q22021
Project Members
Company
Kim Musgrave
Amgen
Maria Dalton
GSK
Mary Nilsson
Eli Lilly
Q42020
Team recently presented at CSS. Bi-weekly meetings now established